<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="23380">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01912313</url>
  </required_header>
  <id_info>
    <org_study_id>S55484</org_study_id>
    <nct_id>NCT01912313</nct_id>
  </id_info>
  <brief_title>Measuring Nerve Activity in Small Human Intestinal Biopsies in IBS (Irritable Bowel Syndrome)</brief_title>
  <official_title>Measuring Nerve Activity in Small Human Intestinal Biopsies in IBS (Irritable Bowel Syndrome)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Katholieke Universiteit Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Katholieke Universiteit Leuven</source>
  <oversight_info>
    <authority>Belgium: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rectal biopsies from IBS patients or healthy subjects will be taken.

      Biopsies will be used for:

        1. the isolation of submucosal plexus to perform: 1.1  live nerve recordings and Calcium
           imaging; 1.2  immunohistochemistry; 1.3  mRNA (Messenger ribonucleic acids) isolation
           and real time PCR (Polymerase chain reaction);

        2. culturing biopsies

      On the basis of these observations, the general aim of the study is to move a significant
      step forward in the current knowledge on human ENS (enteric nervous system) in IBS by
      establishing a live imaging method to record enteric nerves activity in small intestinal
      biopsies from humans. This development is unique in its kind as not other research groups
      have reported successful live recordings with calcium imaging in this preparation.

      In particular, the investigators aim:

        1. to develop and validate the technique to measure activity in human enteric nerves in
           the submucous plexus isolated from rectal biopsies from healthy subjects and IBS
           patients;

        2. to characterize this nerve activity in healthy subjects and IBS patients using both
           calcium imaging to evaluate the effect of different neuromodulators,
           immunohistochemistry and rtPCR to determine receptor expression levels and identify
           neurons and glial cells in the submucous ganglia;

        3. to investigate whether the biopsies of IBS patients secrete more modulators/cytokines
           compared to healthy subjects and their potential to activate neurons.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">August 2016</completion_date>
  <primary_completion_date type="Anticipated">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>nerve activity in healthy subjects and IBS patients</measure>
    <time_frame>Starting from the moment biopsies are collected untill nerve activity in samples is lost (approximately 5 hours)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measuring nerve activity in healthy subjects and IBS patients using both calcium imaging to evaluate the effect of different neuromodulators, immunohistochemistry and rtPCR to determine receptor expression levels and identify neurons and glial cells in the submucous ganglia.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">99999999</enrollment>
  <condition>IBS</condition>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Rectal biopsy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Rectal biopsies from IBS patients or healthy subjects will be taken during proctoscopy</intervention_name>
    <arm_group_label>Rectal biopsy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  IBS patients (based on ROME III Criteria)

          -  Healthy subjects

        Exclusion Criteria:

        - All subjects with not IBS related complaints
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guy Boeckxstaens, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Catholic University Leuven and Universitary Hospitals Leuven</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Winde Vanbrabant, MSc</last_name>
    <phone>0032-16-341943</phone>
    <email>winde.vanbrabant@med.kuleuven.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dafne Balemans, MSc</last_name>
    <phone>0032-16-330158</phone>
    <email>dafne.balemans@med.kuleuven.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospitals Leuven</name>
      <address>
        <city>Leuven</city>
        <state>Vlaams-Brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Winde Vanbrabant, MSc</last_name>
      <phone>0032-16-341943</phone>
      <email>winde.vanbrabant@med.kuleuven.be</email>
    </contact>
    <contact_backup>
      <last_name>Dafne Balemans, MSc</last_name>
      <phone>0032-16-330158</phone>
      <email>dafne.balemans@med.kuleuven.be</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 31, 2013</lastchanged_date>
  <firstreceived_date>July 29, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Katholieke Universiteit Leuven</investigator_affiliation>
    <investigator_full_name>Guy Boeckxstaens</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>IBS patients</keyword>
  <keyword>healthy subjects</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Irritable Bowel Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
